MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
APGE — Apogee Therapeutics, Inc. Common Stock
NasdaqApogee Therapeutics, Inc. Common Stock
$135.07
-0.01(-0.01%)
- O
- 135.08
- H
- 135.09
- L
- 135.06
- V
- 5.14M
⏱️ End-of-day dataAs of Sep 2, 2026
APGE — Latest News & Headlines
4 StoriesTop Generate Biomedicines (GENB) Competitors 2026 - MarketBeat
Top Generate Biomedicines (GENB) Competitors 2026 MarketBeat
AbbVie (NYSE:ABBV) Stock: Apogee Deal Deepens Its Immunology Pipeline - kalkine.ca
AbbVie (NYSE:ABBV) Stock: Apogee Deal Deepens Its Immunology Pipeline kalkine.ca
Piotroski F-score stocks: 11 cheap names with improving health - Value Research
Piotroski F-score stocks: 11 cheap names with improving health Value Research
Michael Page Names Paul Harrison as Next Chair in Planned Board Succession - TipRanks
Michael Page Names Paul Harrison as Next Chair in Planned Board Succession TipRanks